Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Swiss Life Private Equity Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$439M
Portfolio companies 6
Rounds per year 0.04
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 6
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Risk Management
  • Information Technology
Summary

Swiss Life Private Equity Partners appeared to be the Corporate Investor, which was created in 1857. The leading representative office of defined Corporate Investor is situated in the Zu00fcrich. The company was established in Europe in Switzerland.

The higher amount of exits for fund were in 2005. The important activity for fund was in 2001. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Swiss Life Private Equity Partners performs on 71 percentage points more the average number of lead investments.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Swiss Life Private Equity Partners, startups are often financed by Techno Venture Management, Oxford Bioscience Partners, Advent International. The meaningful sponsors for the fund in investment in the same round are Techno Venture Management, Yasuda Enterprise Development, Wheatley MedTech Partners. In the next rounds fund is usually obtained by Western Technology Investment, Thuja Capital, Techno Venture Management.

Among the most popular fund investment industries, there are Health Care, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Zeptosens, Phenex Pharmaceuticals, Enanta Pharmaceuticals. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Swiss Life Private Equity Partners:
Typical Co-investors
Swiss Life Private Equity Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Swiss Life Private Equity Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Phenex Pharmaceuticals

Biopharma
Biotechnology
Pharmaceutical
$7M21 Sep 2010 Baden-Württemberg

iolon, inc.

Manufacturing
Optical Communication
Private Social Networking
$7M25 Apr 2002 San Jose, California, United States

Biotechnology
Health Care
Medical
$15M27 Feb 2001 Bern, Switzerland

Acorda Therapeutics

Biotechnology
Developer Platform
Health Care
$33M08 Jan 2001 New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Swiss Life Private Equity Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 439M
Rounds per year 0.04
Peak activity year 2001
Lead investments 0
Follow on index 0.14
Exits 6
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Phenex Pharmaceuticals

Biopharma
Biotechnology
Pharmaceutical
$7M21 Sep 2010 Baden-Württemberg

iolon, inc.

Manufacturing
Optical Communication
Private Social Networking
$7M25 Apr 2002 San Jose, California, United States

Biotechnology
Health Care
Medical
$15M27 Feb 2001 Bern, Switzerland

Acorda Therapeutics

Biotechnology
Developer Platform
Health Care
$33M08 Jan 2001 New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors: